欧盟关税优惠案对发展中国家的影响

欧盟 2 0 0 1年 12月 10日通过的第 2 5 0 1/2 0 0 1号理事会条例就向发展中国家提供优惠关税作出了包括反药品生产在内的五种安排 ,给予 12个发展中国家优于其他发展中国家的关税待遇。印度由此向世贸组织提出申诉 ,认为欧盟条例 (后将其指控限定在药品安排 )违反了关贸总协定第 1条第 1款的规定 ,且不能以授权条款作为抗辩理由。专家组于 2 0 0 3年 12月 1日公布报告 ,支持印度的指控。欧盟就专家组的报告提起上诉。针对欧盟的上诉和其他当事方的意见 ,上诉庭明确了授权条款的地位问题、指控方应承担的提出证据的标准问题、以及非歧视待遇的内涵问题 ,据此 ,欧盟的药品安排被裁定不符合授权条款的规定。上诉庭的裁定意见将对发展中国家在世界贸易组织内享有的权利产生消极和积极两个方面的重要影响

The Effect on Developing Countries by the Eu''''s Preferences Favorite Case

Eu gives the more favorite tariff treatment to the 12 developing countries through the 250I/200I regulation of Eu Council ad Dec.10,2001. Because of this, india claims to WTO and regards that the regulation of Eu doesn't accord to the GATT1(1). The panel supports India in its report of Dec.1,2003. The medical arrangement of Eu is ruled that is out of law. The ruling decision of appellate body will have negative and positive effects to the developing countries in the framwork of WTO.